These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 34442417)
1. Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms Profile. Leta V; Dafsari HS; Sauerbier A; Metta V; Titova N; Timmermann L; Ashkan K; Samuel M; Pekkonen E; Odin P; Antonini A; Martinez-Martin P; Parry M; van Wamelen DJ; Ray Chaudhuri K J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442417 [TBL] [Abstract][Full Text] [Related]
2. Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors. Metta V; Batzu L; Leta V; Trivedi D; Powdleska A; Mridula KR; Kukle P; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357147 [TBL] [Abstract][Full Text] [Related]
3. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach. Antonini A; Stoessl AJ; Kleinman LS; Skalicky AM; Marshall TS; Sail KR; Onuk K; Odin PLA Curr Med Res Opin; 2018 Dec; 34(12):2063-2073. PubMed ID: 30016901 [TBL] [Abstract][Full Text] [Related]
4. [Device-aided therapies in advanced Parkinson's disease]. Timofeeva AA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):54-60. PubMed ID: 28139627 [TBL] [Abstract][Full Text] [Related]
5. Device-Aided Treatment Strategies in Advanced Parkinson's Disease. Timpka J; Nitu B; Datieva V; Odin P; Antonini A Int Rev Neurobiol; 2017; 132():453-474. PubMed ID: 28554418 [TBL] [Abstract][Full Text] [Related]
6. [Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease]. Toth A; Nagy H; Wacha J; Bereczki D; Takáts A Neuropsychopharmacol Hung; 2015 Dec; 17(4):191-6. PubMed ID: 26727723 [TBL] [Abstract][Full Text] [Related]
7. A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies. Salles PA; Liao J; Shuaib U; Mata IF; Fernandez HH J Parkinsons Dis; 2022; 12(6):1703-1725. PubMed ID: 35662127 [TBL] [Abstract][Full Text] [Related]
8. [Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania]. Szász JA; Szatmári S; Constantin V; Mihály I; Rácz A; Domokos LC; Vajda T; Orbán-Kis K Orv Hetil; 2019 Apr; 160(17):662-669. PubMed ID: 31010306 [TBL] [Abstract][Full Text] [Related]
9. Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach. Fabbri M; Rosa MM; Ferreira JJ Drugs Aging; 2018 Dec; 35(12):1041-1054. PubMed ID: 30318555 [TBL] [Abstract][Full Text] [Related]
10. Use of advanced therapies for Parkinson's disease in Norway. Ezat B; Pihlstrøm L; Aasly J; Tysnes OB; Egge A; Dietrichs E Tidsskr Nor Laegeforen; 2017 May; 137(9):619-623. PubMed ID: 28468476 [TBL] [Abstract][Full Text] [Related]
11. Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States. Amjad F; Bhatti D; Davis TL; Oguh O; Pahwa R; Kukreja P; Zamudio J; Metman LV Adv Ther; 2019 Sep; 36(9):2233-2246. PubMed ID: 31278691 [TBL] [Abstract][Full Text] [Related]
12. Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. Odin P; Ray Chaudhuri K; Slevin JT; Volkmann J; Dietrichs E; Martinez-Martin P; Krauss JK; Henriksen T; Katzenschlager R; Antonini A; Rascol O; Poewe W; Parkinsonism Relat Disord; 2015 Oct; 21(10):1133-44. PubMed ID: 26233582 [TBL] [Abstract][Full Text] [Related]
13. Device-aided therapies for advanced Parkinson disease: insights from an international survey. Marsili L; Bologna M; Miyasaki JM; Colosimo C Neurol Sci; 2021 Jul; 42(7):2961-2964. PubMed ID: 33550525 [TBL] [Abstract][Full Text] [Related]
15. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review. Wirdefeldt K; Odin P; Nyholm D CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916 [TBL] [Abstract][Full Text] [Related]
16. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Worth PF Pract Neurol; 2013 Jun; 13(3):140-52. PubMed ID: 23487815 [TBL] [Abstract][Full Text] [Related]
17. Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence? Catalán MJ; Antonini A; Calopa M; Băjenaru O; de Fábregues O; Mínguez-Castellanos A; Odin P; García-Moreno JM; Pedersen SW; Pirtošek Z; Kulisevsky J eNeurologicalSci; 2017 Sep; 8():44-53. PubMed ID: 29260038 [TBL] [Abstract][Full Text] [Related]
18. [Selection of the optimal device-aided therapy in Parkinson's disease]. Kovács N; Aschermann Z; Juhász A; Harmat M; Pintér D; Janszky J Ideggyogy Sz; 2019 Jan; 72(1-2):5-11. PubMed ID: 30785241 [TBL] [Abstract][Full Text] [Related]